AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14695409 — intervention group
Group type: EXPERIMENTAL
Intervention: Double autologous stem-cell transplantation
Number of subjects: 399
Study 10532497 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education program for children with asthma
Number of subjects: 0
Study 10532497 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline allergen levels
Number of subjects: 0
Study 10532497 — intervention group
Group type: EXPERIMENTAL
Intervention: Mold levels
Number of subjects: 0
Study 8712161 — intervention group
Group type: EXPERIMENTAL
Intervention: Elbow supported on a table
Number of subjects: 32
Study 8712161 — intervention group
Group type: COMPARATOR
Intervention: Elbow unsupported
Number of subjects: 32
Study 1932485 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg o.m.
Number of subjects: 0
Study 1932485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7084076 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential compression prophylaxis with 90-100 mm Hg
Number of subjects: 25
Study 7084076 — intervention group
Group type: COMPARATOR
Intervention: Sequential compression with 35 mm Hg
Number of subjects: 25
Study 7084076 — intervention group
Group type: COMPARATOR
Intervention: Heparin 5000 units three times daily
Number of subjects: 25
Study 3909420 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen citrate
Number of subjects: 0
Study 3909420 — intervention group
Group type: COMPARATOR
Intervention: Megestrol acetate (Megace)
Number of subjects: 0
Study 28655066 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniportal video-assisted thoracoscopic surgery (UVATS)
Number of subjects: 126
Study 28655066 — intervention group
Group type: COMPARATOR
Intervention: Classical VATS
Number of subjects: 126
Study 27302101 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer coaching
Number of subjects: 18
Study 27302101 — intervention group
Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 18
Study 24856940 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit class therapy sessions
Number of subjects: 29
Study 24856940 — intervention group
Group type: COMPARATOR
Intervention: Individual therapy sessions
Number of subjects: 29
Study 22431712 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedle device applied to facial skin
Number of subjects: 0
Study 22431712 — intervention group
Group type: COMPARATOR
Intervention: Sham device applied to facial skin
Number of subjects: 0
Study 22431712 — intervention group
Group type: COMPARATOR
Intervention: Microneedle device vs Sham device
Number of subjects: 0
Study 20128831 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling with chlorhexidine
Number of subjects: 13
Study 20128831 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth scaling without chlorhexidine
Number of subjects: 13
Study 20128831 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment modalities
Number of subjects: 13
Study 18606271 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive, interactive virtual pedestrian environment
Number of subjects: 176
Study 15834602 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratus optical coherence tomography (OCT) measurements
Number of subjects: 124
Study 15834602 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratus optical coherence tomography (OCT) measurements with six input parameters
Number of subjects: 124
Study 15834602 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratus optical coherence tomography (OCT) measurements with fifteen input parameters
Number of subjects: 124
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) with high-fat meal
Number of subjects: 20
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) with light meal
Number of subjects: 20
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) with yogurt
Number of subjects: 20
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) with applesauce
Number of subjects: 20
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) 1 hour before light meal
Number of subjects: 20
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) 2 hours after light meal
Number of subjects: 20
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) 1.5 hours before meal
Number of subjects: 20
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) 2 hours before meal
Number of subjects: 20
Study 11936567 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (400 mg) 3 hours before meal
Number of subjects: 20
Study 10631409 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (diclofenac, ketorolac, indomethacin, ibuprofen) used for up to three days after surgery
Number of subjects: 345
Study 10631409 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (diclofenac, ketorolac, indomethacin, ibuprofen)
Number of subjects: 345
Study 7481419 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (30 mg)
Number of subjects: 40
Study 7481419 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (150 mg)
Number of subjects: 40
Study 2251492 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 33
Study 2251492 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 33
Study 7005796 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheie procedure
Number of subjects: 15
Study 7005796 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 15
Study 30717634 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 × 30 s
Number of subjects: 36
Study 30717634 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 × 10 s
Number of subjects: 36
Study 30717634 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 × 10 s
Number of subjects: 36
Study 29155000 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin for 4 weeks
Number of subjects: 192
Study 29155000 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 192
Study 27478346 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Radiofrequency (PRF) administered to a targeted dorsal root ganglion (DRG)
Number of subjects: 44
Study 27478346 — intervention group
Group type: COMPARATOR
Intervention: Transforaminal Epidural Steroid Injection (TFESI)
Number of subjects: 44
Study 25148570 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 784
Study 25148570 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 784
Study 25148570 — intervention group
Group type: COMPARATOR
Intervention: Acarbose and Metformin
Number of subjects: 784
Study 23271771 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 731
Study 23271771 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting (WW)
Number of subjects: 731
Study 19723990 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention-to-treat principle used
Number of subjects: 274
Study 19723990 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict adherence to intention-to-treat principle
Number of subjects: 274
Study 19723990 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusion of patients lost to follow-up
Number of subjects: 274
Study 19723990 — intervention group
Group type: EXPERIMENTAL
Intervention: Method of adjusting for missing data
Number of subjects: 274
Study 19723990 — intervention group
Group type: EXPERIMENTAL
Intervention: Yearly increase in use of intention-to-treat principle
Number of subjects: 274
Study 17149715 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS)
Number of subjects: 20
Study 17149715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15043665 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block with 0.25% bupivacaine 2 mg/kg
Number of subjects: 30
Study 15043665 — intervention group
Group type: COMPARATOR
Intervention: Control group (no caudal block)
Number of subjects: 30
Study 11011333 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab therapy
Number of subjects: 1472
Study 9407413 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg once a day, N = 12)
Number of subjects: 22
Study 9407413 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 10)
Number of subjects: 22
Study 9407413 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg once a day)
Number of subjects: 22
Study 8350339 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg per os once daily (po od)
Number of subjects: 98
Study 8350339 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac (Voltaren) 50 mg per os 3 times a day (po tid)
Number of subjects: 98
Study 3491533 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-supplemented (1.5 g)
Number of subjects: 99
Study 3491533 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NS)
Number of subjects: 99
Study 3491533 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 99
Study 3491533 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 99
Study 31903657 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate plus cetuximab
Number of subjects: 45
Study 31903657 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate alone
Number of subjects: 45
Study 30829524 — intervention group
Group type: EXPERIMENTAL
Intervention: Revealing both successes and failures encountered on the path to success
Number of subjects: 0
Study 30829524 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning about the failures of a successful entrepreneur
Number of subjects: 0
Study 28479175 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 formulated with 2-phenoxyethanol in multidose vials (MDV)
Number of subjects: 500
Study 28479175 — intervention group
Group type: COMPARATOR
Intervention: PCV13 without 2-phenoxyethanol in single-dose syringe (SDS)
Number of subjects: 500
Study 25978746 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate Variability Biofeedback (HRV-BF)
Number of subjects: 154
Study 25978746 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control (WLC)
Number of subjects: 154
Study 23188186 — intervention group
Group type: EXPERIMENTAL
Intervention: RapidArc (RA)
Number of subjects: 8
Study 23188186 — intervention group
Group type: COMPARATOR
Intervention: Conventional Intensity‐Modulated Radiation Therapy (IMRT)
Number of subjects: 8
Study 21242555 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated family history assessment and tailored messages for coronary heart disease, stroke, diabetes, colorectal, breast, and ovarian cancer.
Number of subjects: 4248
Study 21242555 — intervention group
Group type: COMPARATOR
Intervention: Standard preventive message related to lifestyle and screening (control group).
Number of subjects: 4248
Study 18814274 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 300
Study 18814274 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 300
Study 16834834 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg
Number of subjects: 1500
Study 16834834 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 200 mg
Number of subjects: 1500
Study 16834834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500
Study 12719393 — intervention group
Group type: EXPERIMENTAL
Intervention: Low field strength magnetic resonance imaging (MRI)
Number of subjects: 134
Study 12719393 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound imaging
Number of subjects: 134
Study 10770814 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective antibiotic treatment (4 treatments per year)
Number of subjects: 60
Study 10770814 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic antibiotic treatment (3 treatments per year)
Number of subjects: 60
Study 9132691 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (30 mg)
Number of subjects: 16
Study 9132691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8419210 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.6 mM pentoxifylline
Number of subjects: 0
Study 8419210 — intervention group
Group type: COMPARATOR
Intervention: Control group (without pentoxifylline)
Number of subjects: 0
Study 3721670 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide cream (0.1%) applied daily for 14 days under occlusion.
Number of subjects: 10
Study 31934777 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser followed by CPP-ACP
Number of subjects: 80
Study 31934777 — intervention group
Group type: EXPERIMENTAL
Intervention: CPP-ACP
Number of subjects: 80
Study 31934777 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 80
Study 31934777 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preventive measures)
Number of subjects: 80
Study 30450865 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.2% saline solution + oral electrolyte solutions (OES)
Number of subjects: 32
Study 30450865 — intervention group
Group type: COMPARATOR
Intervention: Acetate Ringer solution
Number of subjects: 32
Study 30450865 — intervention group
Group type: COMPARATOR
Intervention: Lactate Ringer solution
Number of subjects: 32
Study 30450865 — intervention group
Group type: COMPARATOR
Intervention: Isotonic sodium bicarbonate (NaHCO3)
Number of subjects: 32
Study 27902984 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy full-term infants
Number of subjects: 24
Study 25640577 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (1000 impulses)
Number of subjects: 72
Study 25640577 — intervention group
Group type: COMPARATOR
Intervention: Placebo (acoustic sham)
Number of subjects: 72
Study 23294668 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-directed intervention
Number of subjects: 180
Study 23294668 — intervention group
Group type: COMPARATOR
Intervention: Comparison condition (alternative website for self-assessment)
Number of subjects: 180
Study 20862456 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 57
Study 20862456 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 57
Study 20862456 — intervention group
Group type: COMPARATOR
Intervention: No patch (non-smokers)
Number of subjects: 57
Study 18350853 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (X group; n = 255)
Number of subjects: 750
Study 18350853 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol-sorbitol chewing gum (XS group; n = 264)
Number of subjects: 750
Study 18350853 — intervention group
Group type: COMPARATOR
Intervention: No gum (C group; n = 231)
Number of subjects: 750
Study 16233981 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation under local anaesthesia (n=30)
Number of subjects: 60
Study 16233981 — intervention group
Group type: COMPARATOR
Intervention: Sapheno-femoral ligation, stripping and multiple avulsions under general anaesthesia (n=30)
Number of subjects: 60
Study 16233981 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation
Number of subjects: 60
Study 16233981 — intervention group
Group type: COMPARATOR
Intervention: Sapheno-femoral ligation, stripping and multiple avulsions
Number of subjects: 60
Study 12679946 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 26
Study 12679946 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 26
Study 11103751 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg orally once daily for 4 days
Number of subjects: 8
Study 7999197 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized teaching from family medicine faculty or well women teachers
Number of subjects: 70
Study 7999197 — intervention group
Group type: COMPARATOR
Intervention: Unstandardized teaching during clinical rotations
Number of subjects: 70
Study 3396475 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (2g IV before surgery)
Number of subjects: 552
Study 3396475 — intervention group
Group type: COMPARATOR
Intervention: Cephazolin (2g IV before surgery and after 8 hours)
Number of subjects: 552
Study 3396475 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 552
Study 3396475 — intervention group
Group type: COMPARATOR
Intervention: Cephazolin
Number of subjects: 552
Study 30938383 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet intervention
Number of subjects: 115
Study 30938383 — intervention group
Group type: COMPARATOR
Intervention: Healthy Eating diet (control)
Number of subjects: 115
Study 28245873 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 21
Study 28245873 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 5 mg/ezetimibe 10 mg combination
Number of subjects: 21
Study 25567031 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief strategic therapy (BST) in conjunction with usual care (UC)
Number of subjects: 81
Study 25567031 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 81
Study 23446769 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon Kyphoplasty (BKP)
Number of subjects: 300
Study 23446769 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical Management (NSM)
Number of subjects: 300
Study 21293900 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication PPI-triple therapy
Number of subjects: 307
Study 21293900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study 21293900 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication PPI-triple therapy (compliant patients)
Number of subjects: 307
Study 21293900 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication PPI-triple therapy (non-compliant patients)
Number of subjects: 307
Study 21293900 — intervention group
Group type: EXPERIMENTAL
Intervention: Difference in eradication rates between compliant and non-compliant patients
Number of subjects: 307
Study 20029761 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) methodology
Number of subjects: 328
Study 20029761 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline results dissemination
Number of subjects: 328
Study 17925021 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg caffeine
Number of subjects: 9
Study 17925021 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 mg/kg caffeine
Number of subjects: 9
Study 17925021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 15476155 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 25
Study 15476155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 11841108 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial acupuncture (needles introduced at a depth of 2 mm)
Number of subjects: 44
Study 11841108 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep acupuncture (needles placed deeply in muscular acupuncture points and trigger points)
Number of subjects: 44
Study 9728836 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine (ROPI)
Number of subjects: 45
Study 9728836 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (BUPI)
Number of subjects: 45
Study 9728836 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% mepivacaine (MEPI)
Number of subjects: 45
Study 7759706 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase/subcutaneous heparin
Number of subjects: 1067
Study 7759706 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase/intravenous heparin
Number of subjects: 1067
Study 7759706 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated rt-PA
Number of subjects: 1067
Study 7759706 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 1067
Study 7759706 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 1067
Study 7759706 — intervention group
Group type: COMPARATOR
Intervention: Patent infarct-related artery
Number of subjects: 1067
Study 7759706 — intervention group
Group type: COMPARATOR
Intervention: Low ejection fraction
Number of subjects: 1067
Study 2278332 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified oesophageal detector device
Number of subjects: 20
Study 110504 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 1000 microgram/h
Number of subjects: 10
Study 110504 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 200 microgram/h
Number of subjects: 10
Study 110504 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 40 microgram/h
Number of subjects: 10
Study 110504 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 8 microgram/h
Number of subjects: 10
Study 31807943 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive multimodal treatment comprising pharmacotherapy and DBT-based cognitive behavioural group psychotherapy (TG)
Number of subjects: 144
Study 31807943 — intervention group
Group type: COMPARATOR
Intervention: Clinical management comprising non-specific counselling (CG)
Number of subjects: 144
Study 31807943 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive multimodal treatment (TG)
Number of subjects: 144
Study 31807943 — intervention group
Group type: COMPARATOR
Intervention: Clinical management (CG)
Number of subjects: 144
Study 31216310 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning classifiers using an 18-CpG signature
Number of subjects: 0
Study 31216310 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning classifiers using subsets of the 18-feature aggregate
Number of subjects: 0
Study 31216310 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-CpG signature mapped to 13 genes
Number of subjects: 0
Study 31216310 — intervention group
Group type: COMPARATOR
Intervention: Comparison with previous studies
Number of subjects: 0
Study 28273587 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 172
Study 28273587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172